Use access key #2 to skip to page content.
$7.22 -0.46 (-5.99%)
12/5/2008 11:51 AM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar rhovero (70.95) Submitted: 3/07/08 7:23 PM : Outperform Start Price: $10.76 ALKS Score: 2.54

Byetta LAR should be approved in 2009-2010

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links